Traumatic Brain Injury Outcomes After Recreational Cannabis Use

References

• Dewan MC, Rattani A, Gupta S, et al. Estimating the global incidence of traumatic brain injury. J Neurosurg. 2018;130(4):1–18.
   PubMed Web of Science ®Google Scholar
• James SL, Theadom A, Ellenbogen RG; Injury GBDTB, Spinal Cord Injury C. Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(1):56–87. doi:10.1016/S1474-4422(18)30415-0
   PubMed Web of Science ®Google Scholar
• Van Praag DLG, Cnossen MC, Polinder S, Wilson L, Maas AIR. Post-traumatic stress disorder after civilian traumatic brain injury: a systematic review and meta-analysis of prevalence rates. J Neurotrauma. 2019;36(23):3220–3232. doi:10.1089/neu.2018.5759
   PubMed Web of Science ®Google Scholar
• Fleminger S. Long-term psychiatric disorders after traumatic brain injury. Eur J Anaesthesiol Suppl. 2008;42:123–130. doi:10.1017/S0265021507003250
   PubMedGoogle Scholar
• Grauwmeijer E, Heijenbrok-Kal MH, Haitsma IK, Ribbers GM. A prospective study on employment outcome 3 years after moderate to severe traumatic brain injury. Arch Phys Med Rehabil. 2012;93(6):993–999. doi:10.1016/j.apmr.2012.01.018
   PubMed Web of Science ®Google Scholar
• Ahmed Z. Current Clinical Trials in Traumatic Brain Injury. Brain Sci. 2022;12(5):527. doi:10.3390/brainsci12050527
   PubMed Web of Science ®Google Scholar
• Hergert DC, Robertson-Benta C, Sicard V, et al. Use of medical cannabis to treat traumatic brain injury. J Neurotrauma. 2021;38(14):1904–1917. doi:10.1089/neu.2020.7148
   PubMed Web of Science ®Google Scholar
• Doshi H, Wiseman N, Liu J, et al. Cerebral hemodynamic changes of mild traumatic brain injury at the acute stage. PLoS One. 2015;10(2):e0118061. doi:10.1371/journal.pone.0118061
   PubMed Web of Science ®Google Scholar
• Mueller C, Lin JC, Sheriff S, Maudsley AA, Younger JW. Evidence of widespread metabolite abnormalities in Myalgic encephalomyelitis/chronic fatigue syndrome: assessment with whole-brain magnetic resonance spectroscopy. Brain Imaging Behav. 2020;14(2):562–572. doi:10.1007/s11682-018-0029-4
   PubMed Web of Science ®Google Scholar
• Sharma AA, Szaflarski JP. Neuroinflammation as a pathophysiological factor in the development and maintenance of functional seizures: a hypothesis. Epilepsy Behav Rep. 2021;16:100496. doi:10.1016/j.ebr.2021.100496
   PubMedGoogle Scholar
• Ravizza T, Balosso S, Vezzani A. Inflammation and prevention of epileptogenesis. Neurosci Lett. 2011;497(3):223–230. doi:10.1016/j.neulet.2011.02.040
   PubMed Web of Science ®Google Scholar
• Semple BD, O’Brien TJ, Gimlin K, et al. Interleukin-1 receptor in seizure susceptibility after traumatic injury to the pediatric brain. J Neurosci. 2017;37(33):7864–7877. doi:10.1523/JNEUROSCI.0982-17.2017
   PubMed Web of Science ®Google Scholar
• Szaflarski J, Burtrum D, Silverstein FS. Cerebral hypoxia-ischemia stimulates cytokine gene expression in perinatal rats. Stroke. 1995;26(6):1093–1100. doi:10.1161/01.STR.26.6.1093
   PubMed Web of Science ®Google Scholar
• Webster KM, Sun M, Crack P, O’Brien TJ, Shultz SR, Semple BD. Inflammation in epileptogenesis after traumatic brain injury. J Neuroinflammation. 2017;14(1):10. doi:10.1186/s12974-016-0786-1
   PubMedGoogle Scholar
• Fabene PF, Navarro Mora G, Martinello M, et al. A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nature Med. 2008;14(12):1377–1383. doi:10.1038/nm.1878
   PubMed Web of Science ®Google Scholar
• Gaston TE, Szaflarski JP. Cannabis for the treatment of epilepsy: an Update. Curr Neurol Neurosci Rep. 2018;18(11):73. doi:10.1007/s11910-018-0882-y
   PubMed Web of Science ®Google Scholar
• Librizzi L, Noe F, Vezzani A, de Curtis M, Ravizza T. Seizure-induced brain-borne inflammation sustains seizure recurrence and blood-brain barrier damage. Ann Neurol. 2012;72(1):82–90. doi:10.1002/ana.23567
   PubMed Web of Science ®Google Scholar
• Chiu CC, Liao YE, Yang LY, et al. Neuroinflammation in animal models of traumatic brain injury. J Neurosci Methods. 2016;272:38–49. doi:10.1016/j.jneumeth.2016.06.018
   PubMed Web of Science ®Google Scholar
• Clausen F, Hanell A, Bjork M, et al. Neutralization of interleukin-1beta modifies the inflammatory response and improves histological and cognitive outcome following traumatic brain injury in mice. Eur J Neurosci. 2009;30(3):385–396. doi:10.1111/j.1460-9568.2009.06820.x
   PubMed Web of Science ®Google Scholar
• Czigner A, Mihaly A, Farkas O, et al. Kinetics of the cellular immune response following closed head injury. Acta neurochirurgica. 2007;149(3):281–289. doi:10.1007/s00701-006-1095-8
   PubMed Web of Science ®Google Scholar
• Karve IP, Taylor JM, Crack PJ. The contribution of astrocytes and microglia to traumatic brain injury. Br J Pharmacol. 2016;173(4):692–702. doi:10.1111/bph.13125
   PubMed Web of Science ®Google Scholar
• Menzel L, Kleber L, Friedrich C, et al. Progranulin protects against exaggerated axonal injury and astrogliosis following traumatic brain injury. Glia. 2017;65(2):278–292. doi:10.1002/glia.23091
   PubMed Web of Science ®Google Scholar
• Nikolian VC, Dekker SE, Bambakidis T, et al. Improvement of blood-brain barrier integrity in traumatic brain injury and hemorrhagic shock following treatment with valproic acid and fresh frozen plasma. Crit Care Med. 2018;46(1):e59–e66. doi:10.1097/CCM.0000000000002800
   PubMed Web of Science ®Google Scholar
• Graham NS, Sharp DJ. Understanding neurodegeneration after traumatic brain injury: from mechanisms to clinical trials in dementia. J Neurol Neurosurg Psychiatry. 2019;90(11):1221–1233. doi:10.1136/jnnp-2017-317557
   PubMed Web of Science ®Google Scholar
• Xing G, Zhang Y, Zhang Y, Adamson MM, Furst AJ, Ashford JW. Editorial: evidence-based anti-inflammatory, anti-hypoperfusion and anti-anxiety/insomnia therapies show promises for TBI-induced post-traumatic symptoms and cognitive deficits: advances in diagnosis and treatment of TBI-induced neurodegeneration and cognitive deficits. Front Neurol. 2021;12:695629. doi:10.3389/fneur.2021.695629
   PubMed Web of Science ®Google Scholar
• Hofmann ME, Frazier CJ. Marijuana, endocannabinoids, and epilepsy: potential and challenges for improved therapeutic intervention. Exp Neurol. 2013;244:43–50. doi:10.1016/j.expneurol.2011.11.047
   PubMed Web of Science ®Google Scholar
• Pacher P, Kunos G. Modulating the endocannabinoid system in human health and disease--successes and failures. FEBS J. 2013;280(9):1918–1943. doi:10.1111/febs.12260
   PubMed Web of Science ®Google Scholar
• Lins BR, Anyaegbu CC, Hellewell SC, et al. Cannabinoids in traumatic brain injury and related neuropathologies: preclinical and clinical research on endogenous, plant-derived, and synthetic compounds. J Neuroinflammation. 2023;20(1):77. doi:10.1186/s12974-023-02734-9
   PubMed Web of Science ®Google Scholar
• Gaston TE, Martin RC, Szaflarski JP. Cannabidiol (CBD) and cognition in epilepsy. Epilepsy Behav. 2021;124:108316. doi:10.1016/j.yebeh.2021.108316
   PubMed Web of Science ®Google Scholar
• Rosenberg EC, Patra PH, Whalley BJ. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection. Epilepsy Behav. 2017;70(Pt B):319–327. doi:10.1016/j.yebeh.2016.11.006
   PubMedGoogle Scholar
• Scott JC, Slomiak ST, Jones JD, Rosen AFG, Moore TM, Gur RC. Association of cannabis with cognitive functioning in adolescents and young adults: a systematic review and meta-analysis. JAMA Psychiatry. 2018;75(6):585–595. doi:10.1001/jamapsychiatry.2018.0335
   PubMed Web of Science ®Google Scholar
• Ligresti A, De Petrocellis L, Di Marzo V. From phytocannabinoids to cannabinoid receptors and endocannabinoids: pleiotropic physiological and pathological roles through complex pharmacology. Physiol Rev. 2016;96(4):1593–1659. doi:10.1152/physrev.00002.2016
   PubMed Web of Science ®Google Scholar
• Hawley LA, Ketchum JM, Morey C, Collins K, Charlifue S. Cannabis use in individuals with spinal cord injury or moderate to severe traumatic brain injury in Colorado. Arch Phys Med Rehabil. 2018;99(8):1584–1590. doi:10.1016/j.apmr.2018.02.003
   PubMed Web of Science ®Google Scholar
• Preuss UW, Huestis MA, Schneider M, et al. Cannabis use and car crashes: a review. Front Psychiatry. 2021;12:643315. doi:10.3389/fpsyt.2021.643315
   PubMed Web of Science ®Google Scholar
• Maas AI, Murray G, Henney H, et al. Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a Phase III randomised, placebo-controlled, clinical trial. Lancet Neurol. 2006;5(1):38–45. doi:10.1016/S1474-4422(05)70253-2
   PubMed Web of Science ®Google Scholar
• Maroon J, Bost J. Review of the neurological benefits of phytocannabinoids. Surg Neurol Int. 2018;9(1):91. doi:10.4103/sni.sni_45_18
   PubMedGoogle Scholar
• Szaflarski JP, Bebin EM. Cannabis, cannabidiol, and epilepsy--from receptors to clinical response. Epilepsy Behav. 2014;41:277–282. doi:10.1016/j.yebeh.2014.08.135
   PubMed Web of Science ®Google Scholar
• Knoller N, Levi L, Shoshan I, et al. Dexanabinol (HU-211) in the treatment of severe closed head injury: a randomized, placebo-controlled, phase II clinical trial. Crit Care Med. 2002;30(3):548–554. doi:10.1097/00003246-200203000-00009
   PubMed Web of Science ®Google Scholar
• Nguyen BM, Kim D, Bricker S, et al. Effect of marijuana use on outcomes in traumatic brain injury. Am Surg. 2014;80(10):979–983. doi:10.1177/000313481408001015
   PubMed Web of Science ®Google Scholar
• Leskovan J, Patel P, Pederson J, Moore A, Afaneh A, B LR. The effects of marijuana use prior to traumatic brain injury on survival. Interdiscip Neurosurg. 2021;25(101139). doi:10.1016/j.inat.2021.101139
   Google Scholar
• A Report of The National Academies of Sciences Engineering and Medicine. The Health Effects of Cannabis and Cannabinoids. The Current State of Evidence and Recommendations for Research. Washington, DC: The National Academies Press; 2017.
   Google Scholar
• Yang YT, Szaflarski JP. The US food and drug administration’s authorization of the first cannabis-derived pharmaceutical: are we out of the haze? JAMA Neurol. 2019;76(2):135–136. doi:10.1001/jamaneurol.2018.3550
   PubMed Web of Science ®Google Scholar
• Temkin NR, Dikmen SS, Wilensky AJ, Keihm J, Chabal S, Winn HR. A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures. N Engl J Med. 1990;323(8):497–502. doi:10.1056/NEJM199008233230801
   PubMed Web of Science ®Google Scholar
• Isenberg D, Prus N, Ramsey F, Gentile N. The modified Rankin Scale can accurately be derived from the electronic medical record. Transform Med. 2022;1(2):31–35. doi:10.54299/tmed/jidk4591
   Google Scholar
• Sadaka F, Patel D, Lakshmanan R. The FOUR score predicts outcome in patients after traumatic brain injury. Neurocrit Care. 2012;16(1):95–101. doi:10.1007/s12028-011-9617-5
   PubMed Web of Science ®Google Scholar
• Weisscher N, Vermeulen M, Roos YB, de Haan RJ. What should be defined as good outcome in stroke trials; a modified Rankin score of 0–1 or 0–2? J Neurol. 2008;255(6):867–874. doi:10.1007/s00415-008-0796-8
   PubMed Web of Science ®Google Scholar
• Li A, Atem FD, Venkatachalam AM, Barnes A, Stutzman SE, Olson DM. Admission Glasgow Coma Scale score as a predictor of outcome in patients without traumatic brain injury. Am J Crit Care. 2021;30(5):350–355. doi:10.4037/ajcc2021163
   PubMed Web of Science ®Google Scholar
• Rimel RW, Giordani B, Barth JT, Jane JA. Moderate head injury: completing the clinical spectrum of brain trauma. Neurosurgery. 1982;11(3):344–351. doi:10.1227/00006123-198209000-00002
   PubMed Web of Science ®Google Scholar
• Foreman BP, Caesar RR, Parks J, et al. Usefulness of the abbreviated injury score and the injury severity score in comparison to the Glasgow Coma Scale in predicting outcome after traumatic brain injury. J Trauma. 2007;62(4):946–950. doi:10.1097/01.ta.0000229796.14717.3a
   PubMedGoogle Scholar
• Hampson AJ, Grimaldi M, Axelrod J, Wink D. Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants. Proc Natl Acad Sci U S A. 1998;95(14):8268–8273. doi:10.1073/pnas.95.14.8268
   PubMed Web of Science ®Google Scholar
• Vandrey R, Raber JC, Raber ME, Douglass B, Miller C, Bonn-Miller MO. Cannabinoid dose and label accuracy in edible medical cannabis products. JAMA. 2015;313(24):2491–2493.
   PubMed Web of Science ®Google Scholar
• Banks JL, Marotta CA. Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke. 2007;38(3):1091–1096. doi:10.1161/01.STR.0000258355.23810.c6
   PubMed Web of Science ®Google Scholar
• Quinn TJ, Dawson J, Walters MR, Lees KR. Reliability of the modified Rankin Scale: a systematic review. Stroke. 2009;40(10):3393–3395. doi:10.1161/STROKEAHA.109.557256
   PubMed Web of Science ®Google Scholar
• Gaston TE, Friedman D. Pharmacology of cannabinoids in the treatment of epilepsy. Epilepsy Behav. 2017;70(Pt B):313–318. doi:10.1016/j.yebeh.2016.11.016
   PubMedGoogle Scholar
• Tenovuo O, Diaz-Arrastia R, Goldstein LE, Sharp DJ, van der Naalt J, Zasler ND. Assessing the severity of traumatic brain injury-time for a change? J Clin Med. 2021;10(1):148. doi:10.3390/jcm10010148
   PubMed Web of Science ®Google Scholar